FREQUENTLY ASKED QUESTIONS
Before we define the engagement.
Clear boundaries are part of good capability design. These answers explain how programs begin, combine, price, and work with a client’s existing experts.
01Do we need to select only one capability?+
No. Capabilities can be engaged individually or combined. We begin with the business objective and dependencies, then recommend the smallest capability mix that can responsibly support the work.
02Where should we begin if the need is not yet well defined?+
A capability diagnostic is the clearest starting point. It organizes the objective, current state, stakeholders, evidence, constraints, risks, and next decisions before a larger program is scoped.
03Can Pharma Americas Group work with our existing suppliers and advisors?+
Yes. Our role can be structured around the client’s approved suppliers, carriers, laboratories, consultants, legal counsel, regulatory advisors, quality professionals, customs specialists, and other authorized partners.
04How are fees determined?+
Fees depend on scope, complexity, stakeholders, jurisdictions, evidence volume, timeline, service intensity, and the engagement model. Professional-services, transaction, freight, testing, specialist, and third-party costs are identified separately where applicable.
05How does the capability model reduce cost?+
The model targets avoidable coordination load, duplicate work, unclear requirements, late evidence gaps, weak handoffs, unmanaged exceptions, decision delay, premium freight, and continuity exposure. Savings are assessed against the client’s actual baseline and are not guaranteed.
06What information is needed to scope an engagement?+
Useful inputs include the organization and intended markets, objective, products or services in scope, forecast or demand assumptions, specifications, documentation, current partners, timing, known constraints, prior issues, and the decision the work must support.
07Does an engagement guarantee supply, approval, clearance, or a specific outcome?+
No. Availability, pricing, capacity, timing, quality evidence, logistics performance, approvals, registrations, import or export decisions, and other outcomes depend on facts, third parties, authorities, and client decisions outside a coordination engagement.
08Does Pharma Americas Group replace our legal, regulatory, quality, clinical, or customs professionals?+
No. We coordinate requirements, information, evidence, owners, decisions, and operational work. Clients retain their own professional advisors, governance, approvals, and final authority.
09Who can request an engagement?+
Capability briefings and client access are intended for qualified organizations. Each request is reviewed for organizational fit, intended markets, service needs, and appropriate professional oversight before access is issued.